Medlab Clinical Ltd - MDC share price
About Medlab Clinical Ltd
Medlab Clinical Limited (Medlab’s) is an Australian biotechnology company. The Company operates through two segments: Nutraceutical and Pharmaceutical Research. Its Nutraceutical segment is engaged in supply of Medlab’s self-branded nutraceutical range, predominantly in Australia. Its Pharmaceutical Research segment is engaged in research activities, which includes depression and oncology, and the supply of cannabis-based medicines. Its pipeline comprises several small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead candidate is NanaBis, which targets for the treatment of bone pain in breast and prostate cancer patients. Its NanoCelle is designed to address known medication problems and addressing global unmet medical needs. The Company's products include NanaBidial, NanoCBD, and MgOptima and CBD.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Try Veye Free for 7 Days
Expert ASX stock picks, in-depth research & buy/sell signals — free for a full week.
No credit card required
Price Chart (MDC)
TOP ASX STOCKS Worth Watching
- ✓ Instant Access
- ✓ No Credit Card Required
- ✓ Free to join · No spam
Free to join · No spam · Unsubscribe anytime
By providing your details, you agree to Veye's Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers. Before you access our services, please read the Financial Services Guide available here.
Discover the Top ASX Stocks to Invest in 2026!
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Other Reports from Veye
Latest Article
